Thomas William LeBlanc, MD

Associate Professor of Medicine
Member of the Duke Cancer Institute
Campus mail 2424 Erwin Road, Suite 602, Durham, NC 27705
Phone (919) 668-6551
Email address thomas.leblanc@duke.edu

Dr. LeBlanc is a medical oncologist, palliative care physician, and patient experience researcher.  His clinical practice focuses on the care of patients with hematologic malignancies, with a particular emphasis on myeloid conditions and acute leukemias including acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPNs / MPDs, CML), as well as some lymphomas and multiple myeloma.  He is an active member of the inpatient non-transplant hematologic malignancies care team, based on the 9100 ward of Duke Hospital.

His research interests converge on common issues faced by patients with cancer, particularly those with high-risk or relapsed/refractory hematologic malignancies. Issues of symptom burden and quality of life are of central importance in these settings, and may lead patients to face difficult decision-making scenarios. Dr. LeBlanc’s research explores the experience of patients and families in these settings, and aims to improve patients experiences living with blood cancers, including the involvement of specialist palliative care services to provide an extra layer of support along with their comprehensive cancer care.  

Dr. LeBlanc is the recipient of a Junior Career Development Award grant from the National Palliative Care Research Center (NPCRC), a Sojourns Scholars Leadership Award from the Cambia Health Foundation, and a Mentored Research Scholar Grant from the American Cancer Society. These grants have funded efforts to better understand the experience of patients living with AML, including studies of symptom burden, quality of life, distress, understanding of prognosis, and treatment decision-making. This work has been mentored by a team of expert researchers, including Drs. Amy Abernethy, James Tulsky, Karen Steinhauser, Kath Pollak, and Peter Ubel.  Dr. LeBlanc's work in palliative care research led to his recognition as an "Inspirational Leader under 40" by the American Academy of Hospice and Palliative Medicine (AAHPM), and was granted "fellow" status from the Academy in 2016. Dr. LeBlanc is the 2017-18 Chair of the ASCO Ethics Committee, and Chairs the Scientific Review Committee of the NIH/NINR-funded Palliative Care Research Cooperative Group (PCRC; www.palliativecareresearch.org). He represents the Duke Cancer Institute, a National Comprehensive Cancer Network (NCCN) member.

He completed residency training in Internal Medicine at Duke, as well as fellowships in Medical Oncology and Hospice and Palliative Medicine.  He graduated from the Duke University School of Medicine, also earning a Master of Arts degree in Philosophy during that time, and served as Chief Medical Resident at the Durham VA Medical Center.  He holds board certifications in Internal Medicine, Medical Oncology, and in Hospice and Palliative Medicine.  He is actively involved with teaching of medical students and housestaff at Duke, particularly with regards to issues of patient-doctor communication, and is mentoring several Duke trainees on research projects.

Education and Training

  • M.D., Duke University, 2006

Publications

Hochman, MJ, Yu, Y, Wolf, SP, Samsa, GP, Kamal, AH, and LeBlanc, TW. "Comparing the Palliative Care Needs of Patients With Hematologic and Solid Malignancies." Journal of pain and symptom management 55, no. 1 (January 2018): 82-88.e1.

PMID
28887271
Full Text

LeBlanc, TW, Fish, LJ, Bloom, CT, El-Jawahri, A, Davis, DM, Locke, SC, Steinhauser, KE, and Pollak, KI. "Patient experiences of acute myeloid leukemia: A qualitative study about diagnosis, illness understanding, and treatment decision-making." December 2017.

PMID
27862591
Full Text

LeBlanc, TW, and Abernethy, AP. "Patient-reported outcomes in cancer care - hearing the patient voice at greater volume." Nature reviews. Clinical oncology 14, no. 12 (December 2017): 763-772. (Review)

PMID
28975931
Full Text

Kayastha, N, Wolf, SP, Locke, SC, Samsa, GP, El-Jawahri, A, and LeBlanc, TW. "The impact of remission status on patients' experiences with acute myeloid leukemia (AML): an exploratory analysis of longitudinal patient-reported outcomes data." Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (November 18, 2017).

PMID
29151174
Full Text

LeBlanc, TW, Bloom, N, Wolf, SP, Lowman, SG, Pollak, KI, Steinhauser, KE, Ariely, D, and Tulsky, JA. "Triadic treatment decision-making in advanced cancer: a pilot study of the roles and perceptions of patients, caregivers, and oncologists." Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (November 4, 2017).

Full Text

El-Jawahri, A, Traeger, L, Greer, JA, VanDusen, H, Fishman, SR, LeBlanc, TW, Pirl, WF, Jackson, VA, Telles, J, Rhodes, A, Li, Z, Spitzer, TR, McAfee, S, Chen, Y-BA, and Temel, JS. "Effect of Inpatient Palliative Care During Hematopoietic Stem-Cell Transplant on Psychological Distress 6 Months After Transplant: Results of a Randomized Clinical Trial." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 35, no. 32 (November 2017): 3714-3721.

PMID
28926288
Full Text

Unroe, KT, Ast, K, Chuang, E, Schulman-Green, D, Gramling, R, and AAHPM Research Committee Writing Group, . "The Implementation of Measuring What Matters in Research and Practice: Series Commentary." Journal of pain and symptom management 54, no. 5 (November 2017): 772-775.

PMID
28729008
Full Text

LeBlanc, TW. "Advance Care Planning and Palliative Care Specialists in Malignant Hematology and Stem-Cell Transplantation: On Why It Takes A Village." Journal of oncology practice (October 5, 2017): JOP2017026930-.

PMID
28981390
Full Text

To, THM, LeBlanc, TW, Eastman, P, Neoh, K, Agar, MR, To, LB, Rowett, D, Vandersman, Z, and Currow, DC. "The Prospective Evaluation of the Net Effect of Red Blood Cell Transfusions in Routine Provision of Palliative Care." Journal of palliative medicine 20, no. 10 (October 2017): 1152-1157.

PMID
28598239
Full Text

LeBlanc, TW. "Hope, Phase I Trials, and Palliative Care: So You're Telling Me There's a Chance?." Journal of oncology practice 13, no. 10 (October 2017): 675-677.

PMID
28850313
Full Text

Pages